Friday, November 27, 2015

JAGSONPAL PHARMACEUTICALS LTD :- OLD IS GOLD

Dear friends,



 Now we are looking in to one more pharma stock is now available very attractive price for long term portfolio. 





"JAGSONPAL PHARMACEUTICALS LTD"







Founded in 1964 the company specializes in developing and manufacturing bulk drugs and pharmaceutical formulations. Over the past 52 years the firm has grown by leaps and bounds. The firm is committed to sustainable growth and is aggressively pursuing growth through market penetration, market expansion and multi-national expansion.

Jagsonpal is ranked 68th in the Indian pharmaceutical industry. The industry is comprised of over 28,000 manufacturing units putting Jagsonpal in the ivy league of the Indian Pharmaceutical companies. The firm’s objective is to increase market share and become a dominant player in the Indian Pharmaceutical Industry.


Jagsonpal has an expanding international portfolio of affiliates, joint ventures and representative offices across the globe making it a truly international operation. The firm is represented by 2,500 agents worldwide and has offices in 3 continents. The company’s operations span Russia, Brazil, USA, Ukraine, Sri Lanka, Cameroon, Thailand, Argentina, Germany, Switzerland, Korea, Egypt and Vietnam making Jagsonpal's reach truly global.



        COMPANY STORY




In 1964 Jagsonpal started from humble beginnings with Mr. Jagmohan S. Kochhar operating a chemists shop in Delhi. Soon he expanded into making formulations. Mr. Kochhar’s vision was to spread health and healing in India on a larger scale. He was at the helm of the company from its inception, through the startup phase. Even though Jagsonpal was a small business at the time, his vision was to create one of India’s premiere pharmaceutical companies.


In 1978, Fourteen years later, the company had outgrown the startup phase and was incorporated as a private limited company. Jagsonpal was now a fast growing pharmaceutical company. The firm was committed to healing India with quality pharmaceutical products and had its eyes firmly set on becoming one of the country’s leading pharmaceutical companies.


In 1986 Jagsonpal went public on the BSE with an issue of 17.76 lakh (One hundred thousand) shares. This was the first time the firm had tapped the capital markets. Jagsonpal had come a long way from its birth as a chemists shop in Delhi. After this there was no looking back and Jagsonpal had its eyes set firmly on the future.
In 1994 the company was listed on the NSE. This trait of not being content with the status quo has become a core part of Jagsonpal’s company culture. Commitment to growth is ingrained in the very soul of the company and this is reflected in the Jagsonpal’s current aggressive growth strategy.





       MULTI-NATIONAL PRESENCE 

    

The firm is already a multi-national player with a presence in over 15 countries. Jagsonpal reaps substantial benefits by being a global player. The firm sells its existing products in new international markets. The firm is able to share research and development costs with foreign companies by licensing its own products to them. Jagsonpal has also obtained licenses from foreign companies to sell their products in India.


Jagsonpal’s operations span Russia, Brazil, USA, Ukraine, Sri Lanka, Cameroon, Thailand, Argentina, Germany, Switzerland, Korea, Egypt and Vietnam making Jagsonpal's reach truly global.


The Company has an expanding international portfolio of affiliates, joint ventures and representative offices across the globe. A core part
of Jagsonpal’s strategy is to grow through international expansion.
The firm welcomes strategic alliances with foreign companies that foster technology sharing, joint research and development, entry into new markets or new product development.




 The following are Jagsonpal’s top selling brands:


BRAND COMPOSITION

Lycored

Lycopene with Phytonutrients

Maintane

Allylestrenol

Metadec

Nandralone Decanoate

Metabol

Nandralone Phenyl Propionate

Doxypal DR

Doxycycline Delayed Release

Parvon

Dextropropoxyphene HCI

Indocap SR

Indomethacin Sustained Release



   Promoter holding 69.2% stake in company, Jgsonpal's last year topline 140cr and bottom line 1.2cr but market cap is only 96cr ( market cap ff only 30cr) , stock trading 1 time book value is bellow industry level, Company having 74 cr free reserve with 34 book value.

   A 50 year old company have clean balance sheet with good brand products stock trading very attractive price, long term investor buy @ current price and buy more in correction (if any ) and hold in portfolio, Jagsonpal give unbelievable return in long term.

  Stock trading both NSE and BSE @ 37.50 LEVEL, before buy a stock take advice from certified person.



  Disclosure :- I am holding Jagsonpal company's shares in my portfolio.


10 comments:

  1. Sir any advise on shree hari chemicals export ltd.

    ReplyDelete
  2. Sir any viev on shree hari chemicals export s ltd.

    ReplyDelete
  3. Hi, ur view on Sankhya infotech?

    ReplyDelete
  4. Excellent script. Regular watch. Major loss before market. But today confident

    ReplyDelete
  5. why its topline and bottomline decreasing since last 4-5 years?

    ReplyDelete
    Replies
    1. Last 4 years company not produced new products, but coming years we expect new products hit market

      Delete